Page last updated: 2024-11-13

bacoside a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bacoside A: from Bacopa monnieri; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
BacopagenusA plant genus of the family Plantaginaceae. Members contain bacopaside, bacopasaponins and other dammarane type jujubogenins.[MeSH]PlantaginaceaeA plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.[MeSH]

Cross-References

ID SourceID
PubMed CID92043183
CHEBI ID184024
MeSH IDM0484345

Synonyms (9)

Synonym
bacoside a
(5r,8r,9s,10s,13r,14r,17s)-3-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-10-(hydroxymethyl)-17-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,14-tetramethyl-1,2,3,5,6,7,9,11,12,13,15,17-dode
CHEBI:184024
11028-00-5
dammar-24-en-16-one, 3-((alpha-l-arabinopyranosyl-o-beta-d-glucopyranosyl)oxy)-19,20-dihydroxy-
bacoside-a
gynostemma pentaphyllum p.e. gypenoside
CS-0018310
HY-N1989

Research Excerpts

Overview

Bacoside A is a major phytocompound in B.

ExcerptReferenceRelevance
"Bacoside A is a major phytocompound in B."( Copper and iron metal resistant rhizospheric bacteria boost the plant growth and bacoside A content in
Bajaj, R; Chaudhary, SP; Jayashree, S; Joshi, SM; Kumar, V; Kushwaha, RK; Mastan, A; Patel, H, 2023
)
1.86

Treatment

The bacoside A and bromelain treatments significantly decreased the level of TBARS. Increase in the DNA yield and expression of amplified AChE gene products were observed in the brain compared to only dichlorvos treated mice.

ExcerptReferenceRelevance
"The bacoside A and bromelain treatments significantly decreased the level of TBARS (pā€‰<ā€‰0.05, (pā€‰<ā€‰0.01) and PCC whereas, increase in the DNA yield and expression of amplified AChE gene products were observed in the brain compared to only dichlorvos treated mice."( Defensive proclivity of bacoside A and bromelain against oxidative stress and AChE gene expression induced by dichlorvos in the brain of Mus musculus.
Bhatt, DK; Bist, R; Chaudhary, B, 2021
)
1.41
"Bacoside A co-treatment maintained the N-nitrosodiethylamine-induced alterations at near normal level."( Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats.
Geetha, A; Janani, P; Parthasarathy, C; Ravisankar, B; Sivakumari, K, 2010
)
1.38

Bioavailability

ExcerptReferenceRelevance
" In contrast, the aglycones and their derivatives showed better binding affinity and good CNS drug-like properties, were well absorbed through the intestines and had good blood brain barrier (BBB) penetration."( In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri.
Buckle, MJ; Chin, SP; Chung, LY; Kiew, LV; Ramasamy, S; Sukumaran, SD, 2015
)
0.69
" Bioavailability as well as binding of neuroprotective agents (such as bacosides) to these receptors is controlled by the Blood Brain Barrier (BBB)."( Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I.
Baby, S; Sekhar, VC; Viswanathan, G, 2019
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (56)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (19.64)29.6817
2010's41 (73.21)24.3611
2020's4 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.02 (24.57)
Research Supply Index4.08 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (8.62%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (91.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]